Corcept Therapeutics Incorporated shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Corcept Therapeutics Incorporated by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $500k | 6.0k | 83.11 |
| 2025-06-30 | $429k | 5.8k | 73.40 |
| 2025-03-31 | $5.4M | 47k | 114.22 |
| 2024-12-31 | $2.5M | 49k | 50.39 |
| 2024-09-30 | $2.2M | 47k | 46.28 |
| 2024-06-30 | $1.5M | 47k | 32.49 |
| 2023-12-31 | $1.4M | 42k | 32.48 |
| 2023-09-30 | $1.2M | 42k | 27.25 |
| 2023-06-30 | $942k | 42k | 22.25 |
| 2023-03-31 | $1.0M | 47k | 21.66 |
| 2022-12-31 | $957k | 47k | 20.31 |
| 2022-09-30 | $1.2M | 47k | 25.64 |
| 2022-06-30 | $1.1M | 47k | 23.78 |
| 2022-03-31 | $1.1M | 47k | 22.53 |
| 2021-12-31 | $670k | 34k | 19.79 |
| 2021-09-30 | $666k | 34k | 19.68 |
| 2021-06-30 | $866k | 39k | 22.00 |
| 2021-03-31 | $937k | 39k | 23.79 |
| 2020-12-31 | $1.0M | 39k | 26.16 |
| 2020-09-30 | $756k | 43k | 17.41 |
| 2020-06-30 | $731k | 43k | 16.83 |
| 2020-03-31 | $517k | 43k | 11.90 |
| 2019-12-31 | $526k | 43k | 12.11 |
| 2019-09-30 | $614k | 43k | 14.14 |
| 2019-06-30 | $484k | 43k | 11.15 |
| 2019-03-31 | $510k | 43k | 11.74 |
| 2018-12-31 | $580k | 43k | 13.36 |
| 2018-09-30 | $945k | 67k | 14.02 |
| 2018-06-30 | $683k | 43k | 15.72 |
| 2018-03-31 | $715k | 43k | 16.46 |
| 2017-12-31 | $785k | 43k | 18.07 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated